Although Laurent Beziaud et al. reported that the addition of gabapentin, as an inhibitor for the stemness transition, could also prevent the IFN-γ-mediated induction of CSCs, sulfarotene was of anti-tumor capacity in a dose-dependent manner itself. Here, IFNG is linked to neoplasm.